The latest closing stock price for Acrivon Therapeutics as of June 20, 2025 is 1.18.
An investor who bought $1,000 worth of Acrivon Therapeutics stock at the IPO in 2022 would have $-929 today, roughly -1 times their original investment - a -58.61% compound annual growth rate over 3 years.
The all-time high Acrivon Therapeutics stock closing price was 23.20 on February 14, 2023.
The Acrivon Therapeutics 52-week high stock price is 10.16, which is 761% above the current share price.
The Acrivon Therapeutics 52-week low stock price is 1.05, which is 11% below the current share price.
The average Acrivon Therapeutics stock price for the last 52 weeks is 5.62.
An investor who bought $1,000 worth of Acrivon Therapeutics stock at the IPO in 2022 would have $-929 today, roughly -1 times their original investment - a -58.61% compound annual growth rate over 3 years.
The all-time high Acrivon Therapeutics stock closing price was 23.20 on February 14, 2023.
The Acrivon Therapeutics 52-week high stock price is 10.16, which is 761% above the current share price.
The Acrivon Therapeutics 52-week low stock price is 1.05, which is 11% below the current share price.
The average Acrivon Therapeutics stock price for the last 52 weeks is 5.62.